Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 7.46% is 33% above its 5-year average of 5.60%, around the middle of its 5-year range (1.39%–12.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.59% below its 12-month average of 7.74%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.46%.
DEBT TO ASSETS RATIO
7.46%
DEBT TO ASSETS RATIO AVG TTM
7.74%
DEBT TO ASSETS RATIO AVG 3Y
5.60%
DEBT TO ASSETS RATIO AVG 5Y
5.60%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-3.59%
CURRENT VS 3Y AVG
+33.09%
CURRENT VS 5Y AVG
+33.29%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+8188.07%
vs the sector median at left
Spruce Biosciences, Inc.
Market Cap
$117.76M
Debt to Assets Ratio
7.46%
TTM Avg
7.74%
3Y Avg
5.60%
5Y Avg
5.60%
Market Cap
$118.59M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$118.83M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$115.67M
Debt to Assets Ratio
0.21%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$120.58M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$114.46M
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spruce Biosciences, Inc. (SPRB) | $117.76M | 7.46% | 7.74% | 5.60% | 5.60% |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | 0.04% | N/A | N/A | N/A |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | 0.09% | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | 0.00% | N/A | N/A | N/A |
| Cibus, Inc. (CBUS)vs › | $119.84M | 0.10% | N/A | N/A | N/A |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | 0.21% | N/A | N/A | N/A |
| Seer, Inc. (SEER)vs › | $120.41M | 0.09% | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | 0.12% | N/A | N/A | N/A |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.46M | 0.64% | N/A | N/A | N/A |
| Genelux Corporation (GNLX)vs › | $113.89M | 0.09% | N/A | N/A | N/A |
Debt/Assets
7.5%
Debt/Equity
0.09
Current Ratio
9.23
Interest Coverage
-405.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 7.46% |
| 2026-03-31 | 12.68% |
| 2025-12-31 | 1.39% |
| 2025-09-30 | 8.80% |
| 2025-06-30 | 8.35% |
| 2025-03-31 | 7.25% |
| 2024-12-31 | 6.12% |
| 2024-09-30 | 4.96% |
| 2024-06-30 | 4.89% |
| 2024-03-31 | 4.74% |
| 2023-12-31 | 4.43% |
| 2023-09-30 | 4.48% |
| 2023-06-30 | 4.38% |
| 2023-03-31 | 4.28% |
| 2022-12-31 | 7.37% |
| 2022-09-30 | 6.60% |
| 2022-06-30 | 6.09% |
| 2022-03-31 | 5.61% |
| 2021-12-31 | 5.16% |
| 2021-09-30 | 4.89% |
| 2021-06-30 | 4.65% |
| 2021-03-31 | 4.38% |
| 2020-12-31 | 3.92% |
| 2020-09-30 | 7.91% |
| 2020-06-30 | 11.45% |
| 2019-12-31 | 94.74% |
